Morphic (MORF)
(Delayed Data from NSDQ)
$55.74 USD
+23.90 (75.06%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $55.80 +0.06 (0.11%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Morphic Holding, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 71 | 20 | 45 | 17 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 1 | 71 | 20 | 45 | 17 |
Selling & Adminstrative & Depr. & Amort Expenses | 179 | 134 | 116 | 92 | 64 |
Income After Depreciation & Amortization | -179 | -63 | -96 | -47 | -47 |
Non-Operating Income | 27 | 4 | 0 | 2 | 5 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -152 | -59 | -96 | -46 | -42 |
Income Taxes | 0 | 0 | 0 | -1 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -152 | -59 | -96 | -45 | -43 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -152 | -59 | -96 | -45 | -43 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -188 | -62 | -94 | -46 | -48 |
Depreciation & Amortization (Cash Flow) | -10 | 2 | 2 | 2 | -1 |
Income After Depreciation & Amortization | -179 | -63 | -96 | -47 | -47 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 42.39 | 38.11 | 35.80 | 30.60 | 16.10 |
Diluted EPS Before Non-Recurring Items | -3.59 | -1.55 | -2.67 | -1.47 | -2.69 |
Diluted Net EPS (GAAP) | -3.59 | -1.55 | -2.67 | -1.47 | -2.69 |
Fiscal Year end for Morphic Holding, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 53.60 | 49.43 | 44.74 | 45.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -53.60 | -49.43 | -44.74 | -45.30 |
Non-Operating Income | NA | 8.39 | 8.82 | 8.62 | 6.43 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -45.21 | -40.61 | -36.13 | -38.88 |
Income Taxes | NA | 0.08 | 0.13 | 0.08 | 0.14 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -45.29 | -40.73 | -36.21 | -39.01 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -45.29 | -40.73 | -36.21 | -39.01 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 50.01 | 43.34 | 49.55 | 42.37 |
Diluted EPS Before Non-Recurring Items | NA | -0.91 | -0.94 | -0.73 | -0.92 |
Diluted Net EPS (GAAP) | NA | -0.91 | -1.04 | -0.73 | -0.92 |